Seasoned Leadership Joins to Support Growth and R&D and Meet Demand for Continuous Care Solution in Retinal Disease

Lumata Health, the company focused on ending preventable blindness with continuous ophthalmic care for people facing chronic eye disease, today announced two new executive hires to propel the company into its next phase of expansion to meet the ophthalmic sector’s demand for its retinal disease treatment adherence solution.

Annu Singh has been named Chief Technology Officer, leading the company's strategy and execution to build scalable, data-enabled, AI-assisted eye care. With more than 25 years of experience building platforms and products for Fortune 500 and Global 5000 companies, Annu brings expertise in developing adaptive architectures and launching innovative, patient-centered solutions. Annu has built and scaled platforms from the ground up, serving over 15 million users across health-tech and ed-tech sectors. He has played a pivotal role in multiple companies through acquisition exits totaling $600M and a $1B+ IPO.

Nastran Andersen has joined as Chief Growth Officer, bringing nearly 30 years of experience driving revenue growth in the healthcare industry to the company. She has a proven track record of leading high-performing teams across sales, marketing, and client success, fostering collaboration to achieve business expansion. Nastran has worked with Fortune 10 and Fortune 500 companies, private equity-backed firms, and small- to mid-sized organizations across provider organizations, health plans, post-acute, and emerging areas such as new care models and age tech.

“This year has been a period of significant expansion as we continue to meet the demand for our proven continuous care solution for people living with vision-threatening eye disease,” said Landon Grace, CEO of Lumata Health. “The exceptional talent we’ve brought on positions us to accelerate adoption among physicians, pharmaceutical partners, and patients. As we broaden our footprint and invest in new technologies, we remain committed to advancing the standard of care for chronic eye-disease management, strengthening visit and treatment adherence to ensure patients receive the care they need when they need it.”

Lumata Health offers a continuous care model to patients with retinal diseases, powered by its data-driven predictive analytics platform that anticipates patient needs beyond the clinic and proactively delivers education and support at critical points in the treatment journey. Between patients’ visits to the office, the company’s trained ophthalmic technicians reinforce the retina specialist’s treatment plan, identify and resolve barriers to care, and coordinate logistics that often disrupt treatment.

About Lumata Health

Lumata Health is focused on eliminating preventable blindness with continuous ophthalmic care for people facing vision-threatening chronic eye disease. The company partners with eye-care practices and pharmaceutical companies to provide personalized, between-visit support that helps patients adhere to their medication treatment plans and proactively participate in preserving their vision. The company is backed by LRVHealth, McKesson Ventures, and Cencora Ventures, with participation from other venture firms, including Cortado Ventures. For more information, visit www.lumatahealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250917514200/en/

“This year has been a period of significant expansion as we continue to meet the demand for our proven continuous care solution for people living with vision-threatening eye disease,” said Landon Grace, CEO of Lumata Health.